Pharma and Biotech
Dividend | |
Latest XD Date (Final) | n/a |
Latest Pay Date (Final) | n/a |
Meetings | |
AGM | 08-Feb-2024 |
EGM | n/a |
GMs | 17-Feb-2020 |
Announcements | |
Trading announcement | 24-Oct-2022 |
IMSs | n/a |
Drilling Report | n/a |
Results | |
Final results | 29-Nov-2023 |
Interim results | 22-May-2024 |
Q1 Results | 22-May-2024 |
Q2 Results | 22-May-2024 |
Q3 Results | 22-Aug-2024 |
Q4 Results | 29-Nov-2023 |
Annual Report | 13-Dec-2022 |
Year End | 30-Sep-2025 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 35.60p |
Change Today | -3.40p |
% Change | -8.72 % |
52 Week High | 48.00p |
52 Week Low | 34.00p |
Volume | 118,205 |
Shares Issued | 739.79m |
Market Cap | £263.37m |
Beta | 0.48 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
13:45 | 3 @ 35.64p |
12:40 | 44 @ 36.00p |
11:41 | 5,682 @ 36.00p |
11:41 | 6,318 @ 36.00p |
11:38 | 7,236 @ 35.61p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research